Home/Filings/4/0001267602-19-000140
4//SEC Filing

Kaba Samer 4

Accession 0001267602-19-000140

CIK 0001267602other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:28 PM ET

Size

4.6 KB

Accession

0001267602-19-000140

Insider Transaction Report

Form 4
Period: 2019-09-30
Kaba Samer
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-09-30$0.57/sh+1,249$71273,985 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.

Issuer

ALIMERA SCIENCES INC

CIK 0001267602

Entity typeother

Related Parties

1
  • filerCIK 0001773634

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:28 PM ET
Size
4.6 KB